• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IPG MFG SWITZERLAND PROTECTA CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IPG MFG SWITZERLAND PROTECTA CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number D364TRG
Device Problems Over-Sensing (1438); Defibrillation/Stimulation Problem (1573); Invalid Sensing (2293)
Patient Problems Atrial Tachycardia (1731); Ventricular Fibrillation (2130); Ventricular Tachycardia (2132)
Event Date 08/31/2016
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical products: linox smart lead, implanted: (b)(6) 2012.Product event summary: the device was not returned for analysis.However, performance data collected from the device was received and analyzed.Analysis of the device memory indicated there was a pr logic detection.The supra ventricular (svt) limit was programmed to 260ms and the ventricular median rate of the arrhythmia was 250ms which caused wavelet to stop withholding and provide therapy.Analysis of the device memory indicated an inappropriate vf detection.Analysis of the device memory indicated oversensing due to emi (electromagnetic interference)/noise.Analysis of the device memory indicated the unexpected delivery of a ventricular tachyarrhythmia therapy.
 
Event Description
It was reported that the patient experienced atrial fibrillation (af) and ventricular fibrillation (vf) and all six high voltage therapies that were delivered were ineffective.It was noted the defibrillation shocks were not effective due to the presence of sinus tachycardia and wavelet withheld therapy.It was noted the patient was hospitalized and the physician performed ablation therapy, which resulted in an external signal being recognized as ventricular fibrillation (vf).The device remains in use.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTA CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
IPG MFG SWITZERLAND
route du molliau 31
tolochenaz 1131
CH  1131
Manufacturer (Section G)
IPG MFG SWITZERLAND
route du molliau 31
tolochenaz 1131
CH   1131
Manufacturer Contact
anne schilling
8200 coral sea st ne
mounds view, MN 55112
7635052036
MDR Report Key6160240
MDR Text Key62334282
Report Number9614453-2016-06753
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/14/2017
Device Model NumberD364TRG
Device Catalogue NumberD364TRG
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/07/2016
Initial Date FDA Received12/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/05/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
4194-78 LEAD, 5076-52 LEAD
Patient Outcome(s) Hospitalization; Required Intervention;
-
-